FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine, and concerns a composition for preventing or treating a disease associated with metabolic disorders or related to triiodothyronine regulated gene expression, containing compounds 
, a pharmaceutically acceptable excipient and an enteric coating.
EFFECT: invention helps preventing formation of genotoxic products in vivo when the active ingredient gets stomach.
16 cl, 2 dwg, 7 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS OF STABLE TIACUMICINES | 2008 |
|
RU2484829C2 |
| COMPOSITION CONTAINING FENOFIBRIC ACID OR PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, AND CAPSULE CONTAINING COMPOSITION | 2008 |
|
RU2500398C2 |
| PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2493831C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING MYCOPHENOLIC ACID OR ITS SALT (MYCOPHENOLATE) | 2007 |
|
RU2381026C2 |
| COMPOSITION CONTAINING PHENOFIBRIN ACID, ITS PHYSIOLOGICALLY ACCEPTABLE SALT OR DERIVATIVE | 2003 |
|
RU2356549C2 |
| ANTISENSE COMPOSITIONS AND METHODS FOR PRODUCTION AND USE THEREOF | 2009 |
|
RU2593939C2 |
| ANTISENSE COMPOSITIONS AND METHODS FOR PRODUCTION AND USE THEREOF | 2009 |
|
RU2739302C2 |
| COMPOSITIONS OF TETRAHYDROBIOPTERINE AND METHODS OF ITS QUANTITATIVE ASSESSMENT | 2008 |
|
RU2486899C2 |
| DOSAGE FORMS OF RISEDRONATE | 2005 |
|
RU2381791C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING MYCOPHENOLIC ACID OR SALT (MYCOPHELATE) | 2002 |
|
RU2338528C2 |
